SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of an Investigation into the Fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger

NEW YORK, May 24, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NRx Pharmaceuticals Inc.  (f/k/a Big Rock Partners Acquisition Corp.) (NASDAQ: NRXP)

The Gross Law Firm has commenced an investigation into the fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger. Shortly after the NRXP 2021 de-SPAC merger closed, NRXP stock began spiraling downwards. The NRXP de-SPAC merger investigation concerns whether this transaction unfairly harmed stockholders and whether all material facts were properly disclosed to stockholders.

NRX PHARMACEUTICALS SHAREHOLDERS SHOULD CONTACT US HERE:
https://securitiesclasslaw.com/mna/nrx-pharmaceuticals-information-request-form/  

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED